Canbay A et al. Increasing risk of disease progression and mortality in non-alcoholic fatty liver disease/non-alcoholic statohepatitis patients with advanced liver disease: A German real-world analysis. (Abstract PS-060),Boursier J et al. Increased risk of mortality with liver disease progression in non-alcoholic fatty liver disease/non-alcoholic statohepatitis patients: An analysis of French national hospital care. (Abstract THU-299)
Sterfte door ebola neemt af bij behandeling met REGN-EB3 en mAb114
aug 2022 | Virale infecties